Faculty Disclosures
In accordance with
the ACCME Standards for Integrity and Independence, the Association of Diabetes
Care & Education Specialists (ADCES) requires anyone in a position to
affect or control continuing education content (e.g., authors, presenters, and
program planners) to disclose all financial relationships with ineligible
companies. It is the responsibility of ADCES to mitigate and disclose all
relevant conflicts of interest. Disclosure of a relationship is not intended to
suggest or condone bias in any presentation but is made to provide participants
with information that might be of potential importance to their evaluation of
the presentation.
Relevant disclosures (or lack thereof)
among educational activity planners and faculty are as follows:
Speaker
Mihail Zilbermint, MD – G.L.G (Consultant / Advisory Board)Guidepoint (Consultant / Advisory Board)Sacramento Healthcare Investors (Ownership Interest)
Planners
Jodi Lavin-Tompkins, MSN, RN, CDCES,
BC-ADM – Stock: Gilead Sciences, Regeneron Pharma
Joanne Rinker, MS, RD, CDCES, LDN, FADCES – No conflicts
of interest
Eileen D. Ward, PharmD, BCAC – No
conflicts of interest
The approval of this educational
offering by the ADCES does not imply endorsement of specific therapies,
treatments, or products discussed in the presentations.
Disclosure and
Mitigation of Relevant Conflicts of Interest
All identified
relevant conflicts of interest have been mitigated.